We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/rme.10.57
Free first page

Bibliography

  • Waddington CH: The Strategy of Genes. George Allen and Unwin, London, UK (1957).
  • Gurdon JB, Melton DA: Nuclear reprogramming in cells. Science322(5909),1811–1815 (2008).
  • Gurdon JB, Byrne JA: The first half-century of nuclear transplantation. Proc. Natl Acad. Sci. USA100(14),8048–8052 (2003).
  • Gurdon JB, Byrne JA, Simonsson S: Nuclear reprogramming and stem cell creation. Proc. Natl Acad. Sci. USA100(Suppl. 1),11819–11822 (2003).
  • Eggan K: Using stem cells and reprogramming to understand disease. Regen. Med.3(6),799–801 (2008).
  • Eggan K: Dolly’s legacy: human nuclear transplantation and better medicines for our children. Cloning Stem Cells9(1),21–25 (2007).
  • Daley GQ: Towards the generation of patient-specific pluripotent stem cells for combined gene and cell therapy of hematologic disorders. Hematology Am. Soc. Hematol. Educ. Program17–22 (2007).
  • Daley GQ, Scadden DT: Prospects for stem cell-based therapy. Cell132(4),544–548 (2008).
  • Kazuki Y, Hiratsuka M, Takiguchi M et al.: Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol. Ther.18(2),386–393 (2010).
  • 10  Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell51(6),987–1000 (1987).
  • 11  Xie H, Ye M, Feng R, Graf T: Stepwise reprogramming of B cells into macrophages. Cell117(5),663–676 (2004).
  • 12  Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4),663–676 (2006).
  • 13  Dimos JT, Rodolfa KT, Niakan KK et al.: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science321(5893),1218–1221 (2008).
  • 14  Park IH, Arora N, Huo H et al.: Disease-specific induced pluripotent stem cells. Cell134(5),877–886 (2008).
  • 15  Nakagawa M, Koyanagi M, Tanabe K et al.: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol26(1),101–106 (2008).
  • 16  Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M: Direct conversion of fibroblasts to functional neurons by defined factors. Nature463(7284),1035–1041 (2010).
  • 17  Zhou Q, Melton DA: Extreme makeover: converting one cell into another. Cell Stem Cell3(4),382–388 (2008).
  • 18  Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA: In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature455(7213),627–632 (2008).